| 000 | 01909 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517164624.0 | ||
| 264 | 0 | _c20180713 | |
| 008 | 201807s 0 0 eng d | ||
| 022 | _a1744-8042 | ||
| 024 | 7 |
_a10.2217/pgs-2017-0078 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTan, Shirley Siang Ning | |
| 245 | 0 | 0 |
_aAssociation of CYP2C19*2 polymorphism with clopidogrel response and 1-year major adverse cardiovascular events in a multiethnic population with drug-eluting stents. _h[electronic resource] |
| 260 |
_bPharmacogenomics _c08 2017 |
||
| 300 |
_a1225-1239 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
| 650 | 0 | 4 | _aClopidogrel |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2C19 _xgenetics |
| 650 | 0 | 4 |
_aDrug-Eluting Stents _xadverse effects |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xadverse effects |
| 650 | 0 | 4 |
_aPolymorphism, Genetic _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTiclopidine _xadverse effects |
| 700 | 1 | _aFong, Alan Yean Yip | |
| 700 | 1 | _aMejin, Melissa | |
| 700 | 1 | _aGerunsin, Jerry | |
| 700 | 1 | _aKong, Khai Liy | |
| 700 | 1 | _aChin, Felicia Yien Yin | |
| 700 | 1 | _aTiong, Lee Len | |
| 700 | 1 | _aLim, Melissa Siaw Han | |
| 700 | 1 | _aAsri, Said | |
| 700 | 1 | _aKhiew, Ning Zan | |
| 700 | 1 | _aVoon, Chi Yen | |
| 700 | 1 | _aMohd Amin, Nor Hanim | |
| 700 | 1 | _aCham, Yee Ling | |
| 700 | 1 | _aKoh, Keng Tat | |
| 700 | 1 | _aOon, Yen Yee | |
| 700 | 1 | _aOng, Tiong Kiam | |
| 773 | 0 |
_tPharmacogenomics _gvol. 18 _gno. 13 _gp. 1225-1239 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2217/pgs-2017-0078 _zAvailable from publisher's website |
| 999 |
_c27404373 _d27404373 |
||